Ann-Sophie Lauenstein

Long-term Therapy With Interleukin 6 Receptor Blockade in Highly Active Neuromyelitis Optica Spectrum Disorder

Marius Ringelstein, Ilya Ayzenberg, Jens Harmel et al. · JAMA Neurology · 2015 · 241 citations

Life Sciences, Neurology, Pharmacotherapy +16

Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial

Albert C. Ludolph, Joachim Schuster, Johannes Dorst et al. · The Lancet Neurology · 2018 · 80 citations · Full text

Medicine, Neurology, Pharmacology +12

Treating neuromyelitis optica with the interleukin-6 receptor antagonist tocilizumab

Ann-Sophie Lauenstein, Mark Stettner, Bernd C. Kieseier et al. · BMJ Case Reports · 2014 · 26 citations

Life Sciences, Neurology, Pharmacotherapy +11

Effects of the COVID-19 Pandemic on Patients With NMO Spectrum Disorders and MOG-Antibody–Associated Diseases

Martin W. Hümmert, Franziska Bütow, Daria Tkachenko et al. · Neurology Neuroimmunology & Neuroinflammation · 2023 · 10 citations · Full text

Medicine, Immunology, Neurology +15